Drug intelligence / Profile preview

chlorozotocin

Development stage
Discontinued
Lead developer
National Cancer Institute
Modality
Small Molecules
Administration
Intravenous
01

Overview

Chlorozotocin is a water-soluble chloroethyl nitrosourea derivative and an analog of streptozocin. As an alkylating agent, it functions by attaching alkyl groups to DNA, resulting in interstrand cross-links and DNA strand breaks that interfere with DNA replication and transcription, ultimately leading to cell death. It was specifically developed to incorporate a glucose moiety to enhance uptake by certain cells and potentially reduce myelosuppression compared to other nitrosoureas like carmustine (BCNU). While it demonstrated activity in preclinical models, clinical trials in various solid tumors, including colorectal cancer and melanoma, showed limited efficacy and significant side effects such as thrombocytopenia and renal toxicity (azotemia).

Other names
2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranoseChlorozotocine
02

Targets

DNA

Beyond the preview

Go deeper on chlorozotocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorozotocin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call